STRUCTURE
Preface ........................................................................................................................................................................... 1
I. Introduction.................................................................................................................................................................. 3
1. Magnitude of the problem............................................................................................................................... 4
2. Aetiology and natural history........................................................................................................................... 7
3. Pathogenesis.................................................................................................................................................. 9
4. Classification................................................................................................................................................. 10
5. Risk factors................................................................................................................................................... 11
6. Aim and rationale for screening.................................................................................................................... 12
7. Screening tests............................................................................................................................................. 13
8. Vaccine development.................................................................................................................................... 15
9. Management of cervical dysplasia................................................................................................................ 16
10. Is screening for cervical cancer effective ?...................................................................................................17
11. General principles of cervical cancer screening............................................................................................ 19
12. Cost effectiveness of cervical cancer screening...........................................................................................21
13. Issues in cervical cancer screening in Developing Countries.......................................................................24
14. Reference list................................................................................................................................................ 28
II. Objectives and methodology .................................................................................................................................... 35
1. General objective.......................................................................................................................................... 37
2. Specific objectives......................................................................................................................................... 37
3. Study sites and study development.............................................................................................................. 38
4. Study design including data collection..........................................................................................................40
5. Dissemination of results................................................................................................................................ 42
III. Results..................................................................................................................................................................... 45
III-1. Prevalence and risk factors of cervical neoplasia in Nicaragua...........................................................................45
III-2. Determinants of cervical cancer screening in a poor area.................................................................................... 55
III-3. Successful involvement of community health workers in the promotion of cervical cancer screening................. 69
III-4. Performance of screening tests............................................................................................................................83
III-4-1. Performance of screening tests in research conditions..................................................................................... 83
III-4-2. Performance of the acetic acid test in field conditions....................................................................................... 99
III-4-3. Improving quality of cytology........................................................................................................................... 111
III-5. Decentralising diagnosis and treatment.............................................................................................................. 121
III-6. Integration of cervical screening in family planning clinics................................................................................. 131
IV. Discussion............................................................................................................................................................. 141
1. Contribution of this work to the field............................................................................................................ 143
2. Relevance of cervical cancer screening programmes in low resource settings.......................................... 144
3. Strategies to reach high-risk groups for screening...................................................................................... 145
4. Selection of a screening test in resource-poor settings.............................................................................. 146
5. Options for service delivery......................................................................................................................... 148
6. Overall conclusions.....................................................................................................................................149
7. Reference list.............................................................................................................................................. 151
V. Executive summary................................................................................................................................................ 153
1. Context and objectives................................................................................................................................ 155
2. Results........................................................................................................................................................ 155
3. Discussion and conclusions........................................................................................................................ 158
VI. Samenvatting ........................................................................................................................................................ 159
1. Achtergrond en objectieven........................................................................................................................ 161
2. Resultaten...................................................................................................................................................162
3. Discussie en conclusies.............................................................................................................................. 165
VII. Abbreviations........................................................................................................................................................167
Acknowledgements.....................................................................................................................................................171